Media Coverage

New Frontiers in Drug Discovery: Applying CRISPR/Cas9 Genome Engineering to the Drug Pipeline

genome

Xtalks

Dr. Anne-Marie Zuurmond, Associate Director of Genome Engineering at Charles River, spoke with Xtalks about how the CRISPR/Cas9 genome editing tool works and how it could streamline drug discovery.

Read the full article